Daily Pickings on GMO foods and pharmaceuticals

Medicine and money 18 August 2016

How to win friends and influence people 23 February 2016

"If you control food, you control the population" 30 January 2016

Zika virus: GMO mosquitoes? Vaccines? 29 January 2016

Snake-oil salesmen 09 September 2015

Totalitarian science 07 August 2015

You are what you eat 26 May 2015

Ebola - pandemic or ploy? 12 October 2014

GMO, Ukraine and TTIP 02 September 2014

GM Watch, Dr Huber and William Engdahl 05 July 2014

Lubricating the Wheels of the GMO Trojan

Monsanto’s Biotech Public Relations Makeover: Lubricating the Wheels of the GMO Trojan Horse By Colin Todhunter

Monsanto believes it is having trouble getting its message across to the public. Last year, it began a makeover. It realised that it and GMOs have an image problem.

According to the Holmes Report, an information service following the public relations industry, Monsanto has embarked on an international campaign by upgrading its association with Fleishman Hillard, one of the biggest public relations firms in the US.

Trans-Pacific Partnership Reveals Deadly Cost of American Patents

Trans-Pacific Partnership Reveals Deadly Cost of American Patents by Yves Smith

While US news stories occasionally mention the breathtaking cost of some medications, they almost always skirt the issue of why American drugs are so grotesquely overpriced by world standards. The pharmaceutical industry has managed to sell the story that it’s because they need all that dough to pay for the cost of finding new drugs.

That account is patently false.

Read the full article at: 


Trade agreements are negotiated for the benefit of corporations. TTIP and TTP will drive pharmaceutical company profits and impoverish healthcare for the majority.

Introduction to GMO and pharmaceuticals

The issue of GMO foods polarises opinion between those who see it as the only viable solution to feed a growing global population and those who fear inadequate testing of the technology will lead to dire consequences if implemented without sufficient safeguards. There is an absence of transparency in the testing of GM since regulatory oversight was captured by industry leaders such as Monsanto in the 1980s under Ronald Reagan. Critical Thinking will be assessing the evidence and incentives to suppress data which would prejudice the commercial interests of the GM companies.

The rewards for shareholders and executives of big pharmaceutical companies depend on bringing "blockbuster prescription drugs" to market. They use aggressive marketing techniques to persuade doctors to prescribe their drugs and are financially motivated to sell more and more drugs rather than improve health. We will be exploring these issues and studying the evidence.